Lentiboost formulated, gmpgrade
Ended Purchase Order Awarded
- Contract number
- 75N90024P00380
- Awardee
-
Revvity Gene Delivery GMBH UEI MSN6VLEJCHC5
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Obligated
- $21,000
Award facts
- Contract value 100% obligated
- $21,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Germany
Award details come from SAM.gov/FPDS.
About this award
The Department of Health and Human Services National Institutes of Health Clinical Center awarded a firm-fixed price purchase order to Sirion Biotech GmbH, a foreign-owned for-profit organization, for the delivery of LENTIBOOST formulated, GMP-grade viral vector products. The order, valued at $21,000.00, supported gene therapy research and patient treatments conducted by the NIH Clinical Center. The contract did not have any set-aside designations and Sirion Biotech delivered the requested viral vector products from its facilities in Germany to meet the specified completion date of June 6, 2024.
Quick answers
Who was awarded contract 75N90024P00380?
75N90024P00380 was awarded to Revvity Gene Delivery GMBH by NIH Clinical Center (National Institutes of Health) on May 7, 2024.
How much is contract 75N90024P00380 worth?
The government has obligated $21,000 on 75N90024P00380.
Was contract 75N90024P00380 competed?
The extent of competition for 75N90024P00380 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award